These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 2407580)

  • 1. Handicaps to host defense. Effects of hyperglycemia on C3 and Candida albicans.
    Hostetter MK
    Diabetes; 1990 Mar; 39(3):271-5. PubMed ID: 2407580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The secreted Candida albicans protein Pra1 disrupts host defense by broadly targeting and blocking complement C3 and C3 activation fragments.
    Luo S; Dasari P; Reiher N; Hartmann A; Jacksch S; Wende E; Barz D; Niemiec MJ; Jacobsen I; Beyersdorf N; Hünig T; Klos A; Skerka C; Zipfel PF
    Mol Immunol; 2018 Jan; 93():266-277. PubMed ID: 28860090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Fungicidal and phagocytic activity against "Candida albicans" of human neutrophils in serum depleted in C3 and C4 (author's transl)].
    Kernbaum S
    Ann Microbiol (Paris); 1975 Jan; 126(1):75-81. PubMed ID: 1103674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phagocytosis of Candida albicans by polymorphonuclear leukocytes from normal and diabetic subjects.
    Jackson RA; Bryan CS; Weeks BA
    Adv Exp Med Biol; 1979; 121B():33-7. PubMed ID: 121033
    [No Abstract]   [Full Text] [Related]  

  • 5. An iC3b receptor on Candida albicans: structure, function, and correlates for pathogenicity.
    Gilmore BJ; Retsinas EM; Lorenz JS; Hostetter MK
    J Infect Dis; 1988 Jan; 157(1):38-46. PubMed ID: 2961817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The iC3b receptor on Candida albicans: subcellular localization and modulation of receptor expression by glucose.
    Hostetter MK; Lorenz JS; Preus L; Kendrick KE
    J Infect Dis; 1990 Apr; 161(4):761-8. PubMed ID: 2138655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complement is essential for protection by an IgM and an IgG3 monoclonal antibody against experimental, hematogenously disseminated candidiasis.
    Han Y; Kozel TR; Zhang MX; MacGill RS; Carroll MC; Cutler JE
    J Immunol; 2001 Aug; 167(3):1550-7. PubMed ID: 11466376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IrC2/Bf - A yeast and Borrelia responsive component of the complement system from the hard tick Ixodes ricinus.
    Urbanová V; Hajdušek O; Šíma R; Franta Z; Hönig-Mondeková H; Grunclová L; Bartošová-Sojková P; Jalovecká M; Kopáček P
    Dev Comp Immunol; 2018 Feb; 79():86-94. PubMed ID: 29061482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pathogenicity of Candida albicans].
    Rüchel R
    Immun Infekt; 1991 Aug; 19(4):108-11. PubMed ID: 1937556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neutrophil dysfunction induced by hyperglycemia: modulation of myeloperoxidase activity.
    de Souza Ferreira C; Araújo TH; Ângelo ML; Pennacchi PC; Okada SS; de Araújo Paula FB; Migliorini S; Rodrigues MR
    Cell Biochem Funct; 2012 Oct; 30(7):604-10. PubMed ID: 22610543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular mimicry in Candida albicans. Role of an integrin analogue in adhesion of the yeast to human endothelium.
    Gustafson KS; Vercellotti GM; Bendel CM; Hostetter MK
    J Clin Invest; 1991 Jun; 87(6):1896-902. PubMed ID: 2040685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Immunosuppressive mechanisms in diabetes mellitus].
    Tanaka Y
    Nihon Rinsho; 2008 Dec; 66(12):2233-7. PubMed ID: 19069085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Effect of Short-Term Hyperglycemia on the Innate Immune System.
    Jafar N; Edriss H; Nugent K
    Am J Med Sci; 2016 Feb; 351(2):201-11. PubMed ID: 26897277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Secreted pH-regulated antigen 1 of Candida albicans blocks activation and conversion of complement C3.
    Luo S; Hartmann A; Dahse HM; Skerka C; Zipfel PF
    J Immunol; 2010 Aug; 185(4):2164-73. PubMed ID: 20644161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune dysfunction in patients with diabetes mellitus (DM).
    Geerlings SE; Hoepelman AI
    FEMS Immunol Med Microbiol; 1999 Dec; 26(3-4):259-65. PubMed ID: 10575137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Polimorphonuclear leukocytes and diabetes mellitus].
    Hopps E; Camera A; Caimi G
    Minerva Med; 2008 Apr; 99(2):197-202. PubMed ID: 18431327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opsonic effect of C-reactive protein on phagocytosis and intracellular killing of virulent and attenuated strains of Candida albicans by human neutrophils.
    Richardson MD; Gray CA; Shankland GS
    FEMS Microbiol Immunol; 1991 Nov; 3(6):341-4. PubMed ID: 1812935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human immunodeficiency virus type 1 Tat binds to Candida albicans, inducing hyphae but augmenting phagocytosis in vitro.
    Gruber A; Lell CP; Speth C; Stoiber H; Lass-Flörl C; Sonneborn A; Ernst JF; Dierich MP; Würzner R
    Immunology; 2001 Dec; 104(4):455-61. PubMed ID: 11899432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased susceptibility of TNF-alpha lymphotoxin-alpha double knockout mice to systemic candidiasis through impaired recruitment of neutrophils and phagocytosis of Candida albicans.
    Netea MG; van Tits LJ; Curfs JH; Amiot F; Meis JF; van der Meer JW; Kullberg BJ
    J Immunol; 1999 Aug; 163(3):1498-505. PubMed ID: 10415052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of diabetes mellitus vs. in vitro hyperglycemia on select immune cell functions.
    Daoud AK; Tayyar MA; Fouda IM; Harfeil NA
    J Immunotoxicol; 2009 Mar; 6(1):36-41. PubMed ID: 19519161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.